Senator Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-250,000
Closed -$25.7M 78
2023
Q3
$25.7M Sell
250,000
-155,000
-38% -$16.7M 1.45% 26
2023
Q2
$46.7M Sell
405,000
-245,000
-38% -$27.8M 2.11% 19
2023
Q1
$69.2M Buy
+650,000
New +$70.2M 3.78% 8
2019
Q3
Sell
-2,096,000
Closed -$168M 51
2019
Q2
$168M Sell
2,096,000
-524,000
-20% -$40.1M 3.08% 10
2019
Q1
$208M Hold
2,620,000
4.69% 4
2018
Q4
$191M Sell
2,620,000
-1,310,000
-33% -$92.5M 5.32% 7
2018
Q3
$266M Sell
3,930,000
-1,000,840
-20% -$63.8M 3.43% 13
2018
Q2
$286M Buy
+4,930,840
New +$278M 2.84% 14

Other funds holding MRK

Senator Investment Group's MRK Position: Q4 2023 in Review

Senator Investment Group sold out of Merck (MRK) in Q4 2023, closing a stake of 250,000 shares — an estimated $25.7M sold.

Senator Investment Group first reported a position in MRK in Q2 2018 and held it in 8 quarters. The position peaked at $286M in Q2 2018. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Senator Investment Group reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Senator Investment Group sold 250,000 Merck shares in Q4 2023, an estimated $25.7M.
  • Senator Investment Group first reported a position in Merck in Q2 2018 and held it in 8 quarters.
  • Senator Investment Group's Merck position peaked at $286M in Q2 2018.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Senator Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.